Background: Previous surveys have identified variations in practice patterns related to epidural steroid injections. Since then, the United States Food and Drug Administration (FDA) has required the addition of drug warning labels for injectable corticosteroids. Updated evidence, as well as scrutiny from regulatory agencies, may affect practice patterns.
painful spinal conditions. In the interlaminar technique, injection to the epidural space is fperformed between 2 adjacent lamina. The main goal of ESI is to facilitate therapy by reducing pain with the added benefit of potentially limiting opioid consumption (3) . In systematic reviews, ESIs were associated with short-term improvement in pain intensity and function for lumbar L ow back and neck pain are important causes that lead to disability. Low back pain has an estimated lifetime prevalence of 75-80% of the population (1) . Neck pain has an estimated lifetime prevalence of 50% (2) . Interlaminar epidural steroid injection (ILESI) is a commonly employed interventional procedure used to manage chronic,
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Study Patients
Patients were interventional pain management (IPM) physicians in the United States. A survey link was sent to 1,800 IPM physicians selected from the Accreditation Council for Graduate Medical Education accredited pain medicine fellowship program list as well as the American Society of Interventional Pain Physicians membership database.
Data Collection
Survey data were collected and stored in a password protected account using the online survey service company Survey Monkey (San Mateo, CA). After the initial e-mail link was sent, reminder emails were sent at 1, 2, 3, and 4 weeks. A final e-mail reminder was sent out 4 months later. Completion of the survey was voluntary. Only the principal investigator and actively involved researchers had access to the data. Data were collected between October 28, 2014, and April 2, 2015.
Analysis
Survey responses were analyzed using Survey Monkey and Excel software with frequency analysis.
Results

Demographics
There were 249 IPM physicians who responded to the survey, yielding a 13.8% response rate. Of the respondents, 73% worked in private practice, 21% in academics, 2% in a government hospital, and 4% other, including hospital employment. Of the 238 who reported primary specialty, 69% had an anesthesiology background and 24% had a background in physical medicine and rehabilitation. Other specialties represented were psychiatry, radiology, neurosurgery, and orthopedics.
Respondents had been performing ESIs for a median of 15 years (IQR 9-24 years). For those who perform cervical ILESI, the median number performed per month was 20 (IQR 10-30). For those who perform lumbar ILESI, the median number performed per month was 30 (IQR 10-50). For those performing caudal ESI, the median done per month was 10 (IQR 5-20).
radiculopathy (4) (5) (6) . Similar results have been found in the cervical spine (7) . Combining cervical ESIs with conservative measures provides superior outcomes to either treatment method alone (8) . It is believed that these injections provide relief via anti-inflammatory, irrigative and neuromodulatory effects (9) . In order to accomplish this, medication should be delivered as close to the targeted area as possible. The addition of fluoroscopy to the interlaminar epidural approach has allowed for more precise delivery of the medication to the epidural space and reduced procedure-related complications (10) .
Despite the fact that ESIs have been used for decades, there is no consensus among physicians on the peri-procedural standards, technical approach or effective injectate. A survey from Cluff et al (11) found there is varying practice on almost every technical aspect of ESIs, including the use of fluoroscopy, patient position, and choice of injectate.
Though generally safe, there have been rare instances of catastrophic injuries associated with ESIs. Since the publication of the Cluff et al (11) survey, the label for triamcinolone was updated in 2011 indicating it was not for epidural use. In April 2014 the United States Food and Drug Administration (FDA) required the addition of a warning to drug labels for injectable corticosteroids describing the risks of rare, but serious, neurologic events, including stroke, paralysis, and death (12) . The FDA coordinated a multi-society pain workgroup (MPW) to develop recommendations to minimize risks with ESIs, but consensus was not reached on all suggestions, and the FDA itself has not modified its initial warning based on feedback from the MPW.
The purpose of this study was to identify ILESI practice patterns among United States pain physicians and expound upon previous examinations.
Methods
This study was approved by the Institutional Review Board of our institution.
Survey
A 22-item questionnaire was created to obtain information about practice patterns related to ESIs.
The survey included open-ended and closed-ended questions. Results regarding peri-procedure monitoring and transforaminal epidural steroid injection practices www.painphysicianjournal.com
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Injection Practices
Regarding needle size, for cervical ILESI, 20 gauge (G), 18 G, and 17 G needles were preferred (52.4, 30.9, and 9% of respondents, respectively). Less commonly preferred sizes included 22 G, 19 G, and 16 G needles. Similarly, for lumbar ILESI, 20 G, 18 G, and 17G needles were preferred (44.7, 35.7, 8.9% of respondents, respectively). There was a wider range of less preferred needle sizes, from 15 G to 27 G needles. For caudal ESI, 22 G, 20 G, and 18 G needles were preferred (36.6, 20.9, 20% of respondents, respectively). There was a wide range of less preferred needle sizes, from 16 G to 27 G needles.
Of those who responded to questions regarding image guidance, all used image guidance for cervical ILESI and lumbar ILESI. The percentage of respondents who used particular views is listed in Table 1 . Anteroposterior (AP) views were used by the majority of respondents. For cervical ILESI, 69.6% of respondents used more than one view all the time. For lumbar ILESI, 44.2% of respondents used more than one view all the time. Contrast was used 100% of the time by 73.8 and 69.1% of respondents for cervical and lumbar ILESI, respectively. Contrast was used selectively by 21.9 and 27.1% of respondents for cervical and lumbar ILESI, respectively. Contrast was not used by 4.3 and 3.8% of respondents for cervical and lumbar ILESI, respectively. Live fluoroscopy was used all the time by 70.9 and 62.5% of respondents for cervical and lumbar ILESI, respectively. Live fluoroscopy was used selectively by 15.2 and 18.8% of respondents for cervical and lumbar ILESI, respectively. Live fluoroscopy was not used by 13.9 and 18.7% of respondents for cervical and lumbar ILESI, respectively. For cervical ILESI, 59.4% of respondents always used contrast in combination with live fluoroscopy. For lumbar ILESI, 52.1% of respondents always used contrast in combination with live fluoroscopy. The majority of respondents preferred the loss of resistance technique to identify the epidural space for both cervical and lumbar ILESI. Hanging drop was the second most common technique utilized to confirm the epidural placement. Other preferences are listed in Table 2 .
Regarding level of injection for cervical ILESI, 19.8% of respondents always perform the injection at C7-T1; 63.3% of respondents always perform at either C6-7 or C7-T1. A small percentage of respondents will sometimes perform ILESI at higher levels (C5-6 33.3%, C4-5 12.7%, and C3-4 8% of respondents).
Preferences for injectate solution are listed in Tables 3 and 4 . For local anesthetics, the most commonly 
In 2002, Cluff et al (11) noted that approximately 49% of practices used fluoroscopy for ESI. In comparison, all practitioners in this survey use image guidance for ILESI which aligns with recommendations put forth by several societies (13) . A majority of physicians use multiple views for cervical procedures, with 69.6% of respondents using more than one view all the time. For lumbar ILESI, 44.2% of respondents used more than one view all the time. In our survey contrast was used by 95.7 and 96.2% of respondents when performing cervical and lumbar ILESI, respectively. In comparison, in the Cluff et al (11) survey from 2002, 94% of practices routinely used contrast for ILESI and 6% did not. Cluff et al (11) noted that 91.8% of practices in 2002 reported using the loss of resistance technique to identify the epidural space. Although the overall use of loss or resistance remains about the same (90.3% in our study), use of "hanging drop" for cervical ESI has decreased significantly compared to 2002 (8.1% of individual respondents compared to 52.7% of practices in 2002) (11) .
Our survey found that 36.7% of respondents sometimes perform cervical ILESIs higher than the C7-T1 or C6-C7 level. It has been recommended that cervical ILESI not be performed above the C6-7 level (13). This recommendation is noted to be based on the anatomical gaps in the ligamentum flavum and the smaller epidural space in the cervical area, but not from complications during the procedure itself (13, 14) .
Use of local anesthetics for cervical procedures was noted to be none for 46% of interventionalists likely because cervical local anesthetic administration creates a high risk of profound cardiovascular effect and anesthesia if inadvertently injected in the intrathecal space (15) . In comparison, 57.5% of practice respondents in the survey performed by Cluff et al (11) in 2002 were still using local anesthetics in cervical ESI; 3.8% of these practices were using solely local anesthetic. Lidocaine and bupivacaine are still commonly used for lumbar and caudal ESIs, respectively, with lower risks of intrathecal complications.
Epidural steroid practices have been under significant scrutiny since the labeling for triamcinolone was updated in 2011 stating it was not for epidural use followed by the announcement in 2014 that injectable corticosteroids should carry a warning label about serious adverse events. Even with the label indicating triamcinolone is not for epidural use, practitioners continue to use this steroid for ILESI (3rd most common for cervical, 2nd most common for lumbar and caudal). In our study, we found that most practitioners use the particulate steroid methylprednisolone in 33.9% cervical, 50.4% lumbar, and 50.6% caudal injections. The nonparticulate steroid, dexamethasone, is more commonly used in cervical interlaminar ESIs (24.6% versus 10.5% and 9.6% for lumbar and caudal ESI, respectively).
One of the major limitations to the study was the low response rate of 13.8%. Thus the results may not be representative of all IPM physicians in the US. The questionnaire was kept brief to improve participation in the survey, which limited the collection of valuable details including the rationale behind practice methods and policies.
Recommendations from the MPW were published shortly after final collection of responses for this survey (13) . Nonetheless, interventionalists seemed to be trending towards recommendations set forth by the MPW. Our survey focuses predominantly on injection practices, which include needle size, use of image guidance, level of injection, identification of the epidural space, and preference for injectates. This study elucidates the discrepancies that still exist amongst the practitioners who perform these injections. As the MPW recommendations were published after completion of this survey, future surveys could re-assess ESI practice patterns. More evidence-based guidelines need to be developed to improve the efficacy and safety of these procedures.
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